MedPath

A clinical study to assess the potential effect and safety of SUN-CA on the Risk Factors of Obesity

Phase 3
Conditions
Health Condition 1: null- Overweight or obese individuals with a BMI between 25-30 in the age group of 18-60 years
Registration Number
CTRI/2017/03/008170
Lead Sponsor
Vidya Herbs Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

1. Patients who are willing to give written informed consent.

2. Patient is willing and able to comply with all trial requirements

3.Overweight or obese; BMI between 25-30

Exclusion Criteria

• Subjects with BMI >30

• Cigarette smoker, History of heart, liver and kidney disease, hypertension, pregnancy, lactating, Type 1 diabetes and weight loss medication.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Reduction in body weight and BMI at week 4, 8 and 12 of treatment <br/ ><br> <br/ ><br>2. Muscle mass fat mass ratio, body fat (%) <br/ ><br>Timepoint: 1. Reduction in body weight and BMI at week 4, 8 and 12 of treatment <br/ ><br> <br/ ><br>2. Muscle mass fat mass ratio, body fat (%) <br/ ><br>at Day 1 and week 12
Secondary Outcome Measures
NameTimeMethod
1. Changes in lipid profile (Triglycerides, cholesterol, HDL and LDL) <br/ ><br> <br/ ><br>2. Blood pressure <br/ ><br> <br/ ><br>3. Changes in anthropometric measurements â?? Waist and hip circumference; Waist-hip ratio <br/ ><br> <br/ ><br>4. Quality of life of subjects before and after treatment <br/ ><br> <br/ ><br>5. Incidence and rate of adverse events <br/ ><br> <br/ ><br>Timepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath